Institutional investors purchased a net $475.0 thousand shares of OMER during the quarter ended September 2017, and now own 49.32% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SUSQUEHANNA FINANCIAL GROUP LLLP Bought 714.2 Thousand shares of Omeros Corp